Código QR (código de barras bidimensional)

Second Line Treatment of Non-Small Cell Lung Cancer: Clinical; Pathological and Molecular Aspects of Novel Promising Drugs

Lung cancer still remains a challenging disease with a higher mortality rate in comparison to other cancers. The discovery of oncogene addicted tumours and targeted therapies responsive to these targets lead to a meaningful change in the prognosis of these diseases. Unfortunately, these newer therap...

ver descrição completa

Na minha lista:
Publicado no:Frontiers Research Topics
Principais autores: Umberto Malapelle, Pierlorenzo Pallante
Formato: Livro
Idioma:Inglês
Publicado em: Frontiers Media SA 2017
Assuntos:
R5-920
thema EDItEUR::M Medicine and Nursing
Alectinib
Liquid Biopsy
Non-Small Cell Lung Cancer
Afatinib
Nivolumab
Immunotherapy
Nintedanib
Dacomitinib
Second-Line Treatment
Tyrosine Kinase Inhibitor
Acesso em linha:https://directory.doabooks.org/handle/20.500.12854/59077
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados